Vimarsana
Biggest News Aggregation in the World

Divi S News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Divi S. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Divi S Today - Breaking & Trending Today

Vi Plans to launch 5G in six months - Vimarsana News

Vi Plans to launch 5G in six months

Vi plans to launch 5G services in 6-7 months and expects more clarity on 5G monetisation by then. The telco will switch off its 3G network in FY25 and refarm airwaves in the 2100 MHz band for 4G. Vi has shut down 3G services in some areas and is in discussions with technology partners for the 5G rollout. The company is also exploring advanced technologies like vRAN & ORAN. Jio has completed its 5G rollout nationwide, while Airtel is set to do so by March. Vi continues its fundraise discussions and is considering selling fibre assets and in-building solutions.

Divi's Laboratories stocks: Buy Divi's Laboratories, target price Rs 3742: ICICI Direct - Vimarsana News

Divi's Laboratories stocks: Buy Divi's Laboratories, target price Rs 3742: ICICI Direct

Divi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 98115.86 Crore) operating in Pharmaceuticals sector.

vodafone idea share price: Big Movers on D-Street: What should investors do with IndiGo, Divi's Labs & Vodafone Idea? - Vimarsana News

vodafone idea share price: Big Movers on D-Street: What should investors do with IndiGo, Divi's Labs & Vodafone Idea?

Stocks that were in focus include names like IndiGo, which fell 3.57%, Divi's Labs, which declined 0.55%, and Vodafone Idea, whose shares dropped 2.48% on Wednesday.

Divi's Laboratories stocks: Buy Divi's Laboratories, target price Rs 3762: ICICI Direct - Vimarsana News

Divi's Laboratories stocks: Buy Divi's Laboratories, target price Rs 3762: ICICI Direct

Divi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 99034.38 Crore) operating in Pharmaceuticals sector.

pharma: We are looking to add pharma stocks to our portfolio, find multiplex stocks too expensive: Deepak Shenoy - Vimarsana News

pharma: We are looking to add pharma stocks to our portfolio, find multiplex stocks too expensive: Deepak Shenoy

"There will be a lot more demand for both railways and defence orders that are coming in and while these stocks have run up quite a bit, there is actually a significant room for growth from here even though the prices have run up. Also, some of the domestic consumption stories and high precision engineering stories will make a difference."